TickerFacts.

Company research / CRLBF

Cresco Labs Inc. (CRLBF)

Build a valuation ↗↓ Download CSV

CIK 0001832928 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Cresco Labs Inc. reported revenue of $655.85M. Revenue fell 9.5% from the prior annual period.

Key ratios (year ended 2025-12-31)

49.5%
Gross margin
-4.3%
Operating margin
-20.6%
Net margin
-39.8%
Return on year-end equity
-9.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-10-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-31
Revenue$655.85M$724.34M$770.88M
Cost of Revenue$331.28M$359.89M$408.52M
Gross Profit$324.57M$364.45M$362.37M
Operating Income-$27.99M$107.29M-$87.82M
Depreciation & Amortization$48.71M$59.10M$62.51M
EBITDA$20.73M$166.39M-$25.31M
Net Income-$135.41M-$74.44M-$175.52M
EPS (Diluted)-$0.38-$0.22-$0.54
Total Assets$1.20B$1.36B$1.36B
Total Liabilities$944.80M$967.18M$930.40M
Shareholders' Equity$340.45M$474.85M$505.69M
Cash & Equivalents$57.90M$137.56M$103.43M
Operating Cash Flow$72.89M$132.48M$58.56M
Capital Expenditures$35.14M$19.49M$55.38M
Free Cash Flow$37.75M$112.99M$3.18M
Weighted Average Diluted Shares355.01M345.47M323.82M
EPS (Basic)-$0.38-$0.22-$0.54